Metal oxide-based adsorbents are quite in for wastewater treatment because of their selectivity, stable structure and very low solubility in aqueous systems. To explore the adsorption of methylene blue (MB), Mn 3 O 4 -Bi 2 O 3 adsorbents were made using a wet-impregnation technique with various concentrations of Mn 3 O 4 . The presence of Mn 3 O 4 contents on the surface of monoclinic Bi 2 O 3 was confirmed through representative scanning electron micrographs. The diffractions pertaining to cubic Mn 3 O 4 and monoclinic Bi 2 O 3 were noticed in the XRD pattern of 5% Mn 3 O 4 -Bi 2 O 3 which confirm the composite nature of the adsorbent. XPS analysis revealed the existance of Bi 4f, Bi 4d, Bi 4p, Bi4s, and Mn 2p core levels in Mn 3 O 4 -Bi 2 O 3 . The adsorption study divulged highest efficiency (∼95% and qe = ∼1.4 mgg -1 ) of 5% Mn 3 O 4 -Bi 2 O 3 composite among other contestants in removing 30 ppm MB at 28 ° C, pH 7 and 250 rpm. In addition to the determination of adsorption ability, the effect of preliminary dye concentration (5, 10, 20, and 30 ppm) and contact time (0.5–6 h) on the removal efficiency of prepared adsorbents were also monitored. The adsorption data from the batch experiments were evaluated using the Langmuir, Freundlich, Temkin, and Dubinin-Radushkevich-Kaganer (DRK) adsorption isotherms and pseudo 1 st and 2 nd -order kinetic models. The fitting of adsorption isotherms and kinetic models revealed the formation of adsorbate’s monolayer on the surface of adsorbents through the process of chemisorption. Through FTIR measurement, the MB adsorption onto the effective adsorbent (5% Mn 3 O 4 -Bi 2 O 3 ) was also confirmed. Moreover, TGA analysis showed ∼1.5% weight loss by 5% Mn 3 O 4 -Bi 2 O 3 before MB adsorption whereas ∼2.6% weight loss was noticed after dye adsorption onto the adsorbent. The antifungal activity was evaluated against the fungi A. solani and M. fructicola using the agar well diffusion technique. The 5% Mn 3 O 4 -Bi 2 O 3 composites have exceptional antifungal characteristics compared to Bi 2 O 3 and Mn 3 O 4 , with zone inhibition values of 58.6 and 53.9 mm, respectively.
methylene blue adsorptionmetal oxide adsorbentsdye removaladsorption isotherms
Gefitinib (GFT) is a tyrosine kinase inhibitor drug used as a first-line treatment for patients with advanced or metastatic non-small cell lung, colon, and breast cancer. GFT exhibits low solubility and hence low oral bioavailability, which restricts its clinical application. One of the most important trends in overcoming such problems is the use of a vesicular system. Cubosomes are considered one of the most important vesicular systems used to improve solubility and oral bioavailability. In this study, GFT cubosomal nanoparticles (GFT-CNPs) were prepared by the emulsification method. The selected formulation variables were analyzed and optimized by full factorial design and response surface methodology. Drug entrapment efficiency (EE%), transmission electron microscopy, particle size, polydispersity index, in vitro release and its kinetics, and the effect of storage studies were estimated. The chosen GFT-CNPs were subjected to further investigations as gene expression levels of tissue inhibitors of metalloproteinases-1 (TIMP-1) and matrix metalloproteinases-7 (MMP-7), colon biomarkers, and histopathological examination of colon tissues. The prepared GFT-CNPs were semi-cubic in shape, with high EE%, smaller vesicle size, and higher zeta potential values. The in vivo data showed a significant decrease in the serum level of embryonic antigen (CEA), carbohydrate antigen 19-9 (CA 19-9), and gene expression level of TIMP-1 and MMP-7. Histopathological examination showed enhancement in cancer tissue and highly decreased focal infiltration in the lamina propria after treatment with GFT-CNPs.
The genesis of cancer is a precisely organized process in which normal cells undergo genetic alterations that cause the cells to multiply abnormally, colonize, and metastasize to other organs such as the liver, lungs, colon, and brain. Potential drugs that could modify these carcinogenic pathways are the ones that will be used in clinical trials as anti-cancer drugs. Resveratrol (RES) is a polyphenolic natural antitoxin that has been utilized for the treatment of several diseases, owing to its ability to scavenge free radicals, control the expression and activity of antioxidant enzymes, and have effects on inflammation, cancer, aging, diabetes, and cardioprotection. Although RES has a variety of pharmacological uses and shows promising applications in natural medicine, its unpredictable pharmacokinetics compromise its therapeutic efficacy and prevent its use in clinical settings. RES has been encapsulated into various nanocarriers, such as liposomes, polymeric nanoparticles, lipidic nanocarriers, and inorganic nanoparticles, to address these issues. These nanocarriers can modulate drug release, increase bioavailability, and reach therapeutically relevant plasma concentrations. Studies on resveratrol-rich nano-formulations in various cancer types are compiled in the current article. Studies relating to enhanced drug stability, increased therapeutic potential in terms of pharmacokinetics and pharmacodynamics, and reduced toxicity to cells and tissues are the main topics of this research. To keep the readers informed about the current state of resveratrol nano-formulations from an industrial perspective, some recent and significant patent literature has also been provided. Here, the prospects for nano-formulations are briefly discussed, along with machine learning and pharmacometrics methods for resolving resveratrol's pharmacokinetic concerns.
Arabian Journal of Chemistry · مجلد 16 (10) · 105118-105118
Arsenic is a known human carcinogen and its contamination of drinking water has been a global challenge. In this study, magnetic activated carbon (MAC) an efficient adsorbent material with adsorption capabilities of activated carbon and magnetic characteristics of magnetite was synthesized by hydrothermal method. Three adsorbent materials MCH, MCH3 and MCNa were synthesized using different activators like HNO3, H3PO4 and NaOH respectively. Structural and morphological features of the adsorbents before and after magnetization were determined by XRD, FTIR, FESEM, EDX and TGA. BJH nitrogen adsorption-desorption isotherm was used to find the surface area and pore size of adsorbents while the surface charge was determined by measuring zeta potential. FESEM images clearly showed the incorporation of magnetite nanoparticles into a porous network while XRD confirmed the formation of magnetite nanoparticles within the network of porous carbon with average crystallite sizes of 6.3, 5.8, 5.5 nm for MCH, MCH3 and MCNa respectively. To examine the adsorption behaviour of As(III) onto the MAC, batch adsorption experiments were conducted with the effect of different parameters like initial concentration, temperature, time, amount of adsorbent and pH. The results showed that MCNa is a potential adsorbent for As(III) with removal efficiency of 99 %. Overall adsorption process follows pseudo 2nd order kinetics while the Langmuir model was found well applicable to the experimental data. Thermodynamics of adsorption and desorption studies suggest that chemisorption is a predominant adsorption mechanism. Cost-effectiveness, novelty and magnetic recovery are the key features making onion-based MAC a potential adsorbent for the removal of As(III) from contaminated water.
Frontiers in Chemistry · مجلد 11 · 1126171-1126171
Besides natural sunlight and expensive artificial lights, economical indoor white light can play a significant role in activating a catalyst for photocatalytic removal of organic toxins from contaminated water. In the current effort, CeO2 has been modified with Ni, Cu, and Fe through doping methodology to study the removal of 2-chlorophenol (2-CP) in the illumination of 70 W indoor LED white light. The absence of additional diffractions due to the dopants and few changes such as reduction in peaks’ height, minor peak shift at 2θ (28.525°) and peaks’ broadening in XRD patterns of modified CeO2 verifies the successful doping of CeO2. The solid-state absorption spectra revealed higher absorbance of Cu-doped CeO2 whereas a lower absorption response was observed for Ni-doped CeO2. An interesting observation regarding the lowering of indirect bandgap energy of Fe-doped CeO2 (∼2.7 eV) and an increase in Ni-doped CeO2 (∼3.0 eV) in comparison to pristine CeO2 (∼2.9 eV) was noticed. The process of e-– h+ recombination in the synthesized photocatalysts was also investigated through photoluminescence spectroscopy. The photocatalytic studies revealed the greater photocatalytic activity of Fe-doped CeO2 with a higher rate (∼3.9 × 10−3 min-1) among all other materials. Moreover, kinetic studies also revealed the validation of the Langmuir-Hinshelwood kinetic model (R2 = 0.9839) while removing 2-CP in the exposure of indoor light with a Fe-doped CeO2 photocatalyst. The XPS analysis revealed the existence of Fe3+, Cu2+ and Ni2+ core levels in doped CeO2. Using the agar well-diffusion method, the antifungal activity was assessed against the fungus M. fructicola and F. oxysporum. Compared to CeO2, Ni-doped CeO2, and Cu-doped CeO2 nanoparticles, the Fe-doped CeO2 nanoparticles have outstanding antifungal properties.
transition metal doping2-chlorophenol degradationLED lightingFe-doped CeO2
High Resolution Image Download MS PowerPoint Slide A total of 14 acyl hydrazine derivatives ( ACH1–ACH14 ) were developed and examined for their ability to block monoamine oxidase (MAO). Thirteen analogues showed stronger inhibition potency against MAO-B than MAO-A. With a half-maximum inhibitory concentration of 0.14 μM, ACH10 demonstrated the strongest inhibitory activity against MAO-B, followed by ACH14, ACH13, ACH8, and ACH3 (IC 50 = 0.15, 0.18, 0.20, and 0.22 μM, respectively). Structure–activity relationships suggested that the inhibition effect on MAO-B resulted from the combination of halogen substituents of the A- and/or B-rings. This series concluded that when –F was substituted to the B-ring, MAO-B inhibitory activities were high, except for ACH6 . In the inhibition kinetics study, the compounds ACH10 and ACH14 were identified as competitive inhibitors, with K i values of 0.097 ± 0.0021 and 0.10 ± 0.038 μM, respectively. In a reversibility experiment using the dialysis methods, ACH10 and ACH14 showed effective recoveries of MAO-B inhibition as much as lazabemide, a reversible reference. These experiments proposed that ACH10 and ACH14 were efficient, reversible competitive MAO-B inhibitors. In addition, the lead molecules showed good blood–brain barrier permeation with the PAMPA method. The molecular docking and molecular dynamics simulation study confirmed that the hit compound ACH10 can form a stable protein–ligand complex by forming a hydrogen bond with the NH atom in the hydrazide group of the compound.
monoamine oxidase B inhibitorsacylhydrazoneshalogen substituentsstructure-activity relationship
Monoamine oxidase (MAO, EC 1.4.3.4) is responsible for the oxidative breakdown of both endogenous and exogenous amines and exists in MAO-A and MAO-B isomers. Eighteen indole-based phenylallylidene derivatives were synthesized via nucleophilic addition reactions comprising three sub-series, IHC, IHMC, and IHNC, and were developed and examined for their ability to inhibit MAO. Among them, compound IHC3 showed a strong MAO-B inhibitory effect with an IC50 (half-maximal inhibitory concentration) value of 1.672 μM, followed by IHC2 (IC50 = 16.934 μM). Additionally, IHC3 showed the highest selectivity index (SI) value of >23.92. The effectiveness of IHC3 was lower than the reference pargyline (0.14 μM); however, the SI value was higher than pargyline (17.16). Structurally, the IHC (-H in the B-ring) sub-series exhibited relatively stronger MAO-B inhibition than the others. In the IHC series, IHC3 (-F in the A-ring) exhibited stronger MAO-B suppression than the other substituted derivatives in the order -F > -Br > -Cl > -OCH3, -CH3, and -H at the 2-position in the A-ring. In the reversibility and enzyme kinetics experiments, IHC3 was a reversible inhibitor with a Ki value of 0.51 ± 0.15 μM for MAO-B. Further, it was observed that IHC3 greatly decreased the cell death caused by rotenone in SH-SY5Y neuroblastoma cells. A molecular docking study of the lead molecule was also performed to determine hypothetical interactions in the enzyme-binding cavity. These findings suggest that IHC3 is a strong, specific, and reversible MAO-B inhibitor that can be used to treat neurological diseases.
monoamine oxidase B inhibitorsParkinson's diseaseisatin derivativesmicrowave-assisted synthesis
Chemical Biology & Drug Design · مجلد 102 (2) · 271-284
Abstract Eight derivatives of benzyloxy‐derived halogenated chalcones (BB1‐BB8) were synthesized and tested for their ability to inhibit monoamine oxidases (MAOs). MAO‐A was less efficiently inhibited by all compounds than MAO‐B. Additionally, the majority of the compounds displayed significant MAO‐B inhibitory activities at 1 μM with residual activities of less than 50%. With an IC50 value of 0.062 μM, compound BB4 was the most effective in inhibiting MAO‐B, followed by compound BB2 (IC50 = 0.093 μM). The lead molecules showed good activity than the reference MAO‐B inhibitors (Lazabemide IC50 = 0.11 μM and Pargyline Pargyline IC50 = 0.14). The high selectivity index (SI) values for MAO‐B were observed in compounds BB2 and BB4 (430.108 and 645.161, respectively). Kinetics and reversibility experiments revealed that BB2 and BB4 were reversible competitive MAO‐B inhibitors with Ki values of 0.030 ± 0.014 and 0.011 ± 0.005 μM, respectively. Swiss target prediction confirmed the high probability in the targets of MAO‐B for both compounds. Hypothetical binding mode revealed that the BB2 or BB4 is similarly oriented to the binding cavity of MAO‐B. Based on the modelling results, BB4 showed a stable confirmation during the dynamic simulation. From these results, it was concluded that BB2 and BB4 were potent selective reversible MAO‐B inhibitors and they can be considered drug candidates for treating related neurodegenerative diseases such as Parkinson's disease.
monoamine oxidase B inhibitorshalogenated chalconesMAO-B selectivityreversible competitive inhibition
The dark brown and white crystals of manganese and tin (Mn2Se3Cl2O7 and SnSe3O4Cl) have been synthesized by solid-state reaction at 450 C. The morphology and the elemental analysis of newly synthesized compounds were studied by SEM and EDX Analysis. SEM analysis reveals that the particle size for Mn2Se3Cl2O7 was found to be 0.2–2.5 μm and for SnSe3O4Cl 2.0–6.0 μm. The EDX studies showed the presence of Mn, Se, O, Cl, and Sn elements. Powdered XRD confirmed the presence of a new phase present in these compounds. Under UV-vis irradiation, the kinetics of methylene blue (MB) degradation catalyzed by produced nanoparticles were monitored. The dye degradation efficiency was estimated, and results reveals that after 150 min of irradiation, almost 75% of the dye was degraded in the presence of Mn compound while 71% degradation was shown by Sn compound. Both composites display antimicrobial activity against Staphylococcus aureus and Escherichia coli with a maximum value of 34.5 mm. The maximum antimicrobial activity shown by Mn-incorporated nanocomposites estimated at 32.5 mm was against Gram-positive bacteria and 26.4 mm against Gram-negative bacteria. Similarly, the maximum antifungal activity shown by Sn incorporated estimated at 33.9 mm was compared to Gram-positive bacteria and 27.8 mm against Gram-negative bacteria.
nanocompositesphotocatalysismethylene blue degradationdye degradation
In the current study, the combined anti-tumor efficacy of bioactive hydroxyapatite nano- particles (HA-NPs) loaded with altretamine (ALT) was evaluated. The well-known fact that HA has great biological compatibility was confirmed through the findings of the hemolytic experiments and a maximum IC50 value seen in the MTT testing. The preparation of HA-NPs was performed using the chemical precipitation process. An in vitro release investigation was conducted, and the results demonstrated the sustained drug release of the altretamine-loaded hydroxyapatite nanoparticles (ALT-HA-NPs). Studies using the JURKAT E6.1 cell lines MTT assay, and cell uptake, as well as in vivo pharmacokinetic tests using Wistar rats demonstrated that the ALT-HA-NPs were easily absorbed by the cells. A putative synergism between the action of the Ca2+ ions and the anticancer drug obtained from the carrier was indicated by the fact that the ALT-HA-NPs displayed cytotoxicity comparable to the free ALT at 1/10th of the ALT concentration. It has been suggested that a rise in intracellular Ca2+ ions causes cells to undergo apoptosis. Ehrlich’s ascites model in Balb/c mice showed comparable synergistic efficacy in a tumor regression trial. While the ALT-HA-NPs were able to shrink the tumor size by six times, the free ALT was only able to reduce the tumor volume by half.
hydroxyapatite nanoparticlesaltretaminedrug deliverysustained drug release